MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink® Personal 5.4 Therapy Management Software for the Mac OS platform. CareLink Personal is a web-based program that helps people with diabetes assess their glucose control through easy-to-read reports, charts, and graphs. The software analyzes data from the user’s insulin pump, continuous glucose monitoring (CGM) device, and blood glucose meter to uncover trends and patterns in daily management that meters and logbooks alone cannot reveal.
